- Scrip
- >>Business
- >>Financing
Finance Watch: Lots Of Money, Big And Small, Flowing Into Drug Development
Big venture capital bets continue in biopharma, including Foresite's new $668m fund and Merck's $125m investment in Moderna, but small VC rounds could be making a comeback. In public company financings, Aslan and Evelo launched in the US, while Ascletis is testing Hong Kong’s IPO market.
The frenzied flow of funds into biopharma venture capital has resulted in a lot of big bets, but recent small financings are encouraging as cash is harder to come by at the earliest stages of drug discovery and development.
Merck & Co. Inc. invested $125m in Moderna Therapeutics LLC in what the messenger RNA (mRNA)-focused firm described...